Psyence Biomedical
Tracked across 1 events · 6 articles · First seen Sep 14, 2026 · Last active Sep 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Psyence Biomedical Ltd. (Nasdaq: PBM) announced on September 14, 2026 the formation of Texas Ibogaine Research Corporation (TIRC), a Texas-based company established to coordinate the Company's U.S. ibogaine development activities, including pharmaceutical-grade supply, regulatory engagement…
Impact: Psyence BioMed is the parent forming TIRC and financing its U.S. ibogaine development activities. The move gives it a dedicated U.S. vehicle for licensing, regulatory and clinical work, a modest positive for its pipeline narrative but subject to execution risk.
Sep 14, 2026 · 6 articles
60
Psyence Biomedical positioned to hold rights PsyLabsPsyence BioMed Forms Texas...
30
Psyence Biomedical appointed project lead John ThorntonPsyence BioMed Forms Texas...
30
Psyence Biomedical appointed CEO Jody AufrichtigPsyence BioMed Forms Texas...
ERGEN INTELLIGENCE
Track Psyence Biomedical live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard